Matches in SemOpenAlex for { <https://semopenalex.org/work/W2375290210> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- W2375290210 abstract "Objective: To evaluate the efficacy of hepatic arterial chemoembolization( TACE) combined with systemic intravenous chemotherapy on liver metastasis of gastric cancer and its influencing factors. Methods: From May 2006 to July 2012,51 cases gastric cancer with liver metastases patients which accepted TACE combined with systemic chemotherapy treatment were retrospective analysised. All patients received 1-3 cycles prior systemic chemotherapy( EOF programs or TOF program),during chemotherapy,patients received intravenous infusion of Shenmai Zhusheye,3-4 weeks after the end of chemotherapy received transcatheter arterial chemoembolization( TACE) therapy. Results: All patients received TACE combined with systemic chemotherapy,objective response rate was 62. 0%,benefit rate was 78. 4%. The objective response rate and 1-year survival rates of the patients with liver metastases alone were 85. 0 %,80. 0%,which were higher the theextrahepatic metastasis patients which were46. 9% and 54. 8%( P 0. 05). The objective response rate,1-year survival rates of single or isolated liver metastasis were 83.3% and 88. 9%,they were higher than the Multiple liver metastases patients which were 51. 5%,51. 5%( P 0. 05). The objective response rate and 1-year survival rates of the rich blood supply type patients were 86. 4%,92. 3%,they were higher thanthe less blood supply type patients whichwere 55. 3%,55. 2%( P 0. 05). Conclusion: TACE combined with systemic chemotherapy treatment on gastric cancer liver metastases have a higher objective response rate,especially on single or isolated liver metastases without extrahepatic metastasis,DSA angiography rich blood supply type patoents." @default.
- W2375290210 created "2016-06-24" @default.
- W2375290210 creator A5001105040 @default.
- W2375290210 date "2013-01-01" @default.
- W2375290210 modified "2023-09-23" @default.
- W2375290210 title "Integrative Medicine Clinical analysis of gastric cancer metastasis" @default.
- W2375290210 hasPublicationYear "2013" @default.
- W2375290210 type Work @default.
- W2375290210 sameAs 2375290210 @default.
- W2375290210 citedByCount "0" @default.
- W2375290210 crossrefType "journal-article" @default.
- W2375290210 hasAuthorship W2375290210A5001105040 @default.
- W2375290210 hasConcept C121608353 @default.
- W2375290210 hasConcept C126322002 @default.
- W2375290210 hasConcept C143998085 @default.
- W2375290210 hasConcept C2776231280 @default.
- W2375290210 hasConcept C2776283816 @default.
- W2375290210 hasConcept C2776694085 @default.
- W2375290210 hasConcept C2779013556 @default.
- W2375290210 hasConcept C71924100 @default.
- W2375290210 hasConcept C90924648 @default.
- W2375290210 hasConceptScore W2375290210C121608353 @default.
- W2375290210 hasConceptScore W2375290210C126322002 @default.
- W2375290210 hasConceptScore W2375290210C143998085 @default.
- W2375290210 hasConceptScore W2375290210C2776231280 @default.
- W2375290210 hasConceptScore W2375290210C2776283816 @default.
- W2375290210 hasConceptScore W2375290210C2776694085 @default.
- W2375290210 hasConceptScore W2375290210C2779013556 @default.
- W2375290210 hasConceptScore W2375290210C71924100 @default.
- W2375290210 hasConceptScore W2375290210C90924648 @default.
- W2375290210 hasLocation W23752902101 @default.
- W2375290210 hasOpenAccess W2375290210 @default.
- W2375290210 hasPrimaryLocation W23752902101 @default.
- W2375290210 isParatext "false" @default.
- W2375290210 isRetracted "false" @default.
- W2375290210 magId "2375290210" @default.
- W2375290210 workType "article" @default.